ImmunoGen, Inc.

STATE STREET CORP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

8,075,671

Value ($000)

239,444

Weight

0.0%

2013 Q4 - 2023 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	239,444	0.0%	8,075,671	12/31/2023
2023 Q3	11/14/2023	151,588	0.0%	9,551,852	9/30/2023
2023 Q2	8/14/2023	149,807	0.0%	7,938,914	6/30/2023
2023 Q1	5/15/2023	65,576	0.0%	17,076,958	3/31/2023
2022 Q4	5/15/2023	86,840	0.0%	17,508,113	12/31/2022
2022 Q3	11/15/2022	69,763	0.0%	14,594,873	9/30/2022
2022 Q2	8/15/2022	81,898	0.0%	18,199,554	6/30/2022
2022 Q1	5/16/2022	65,247	0.0%	13,707,389	3/31/2022
2021 Q4	2/14/2022	59,869	0.0%	8,068,567	12/31/2021
2021 Q3	11/15/2021	51,403	0.0%	9,065,857	9/30/2021
2021 Q2	8/16/2021	70,644	0.0%	10,719,931	6/30/2021
2021 Q1	7/9/2021	73,090	0.0%	9,023,479	3/31/2021
2020 Q4	2/16/2021	56,785	0.0%	8,803,841	12/31/2020
2020 Q3	11/10/2020	32,270	0.0%	8,964,006	9/30/2020
2020 Q2	8/14/2020	42,243	0.0%	9,183,306	6/30/2020
2020 Q1	6/19/2020	19,525	0.0%	5,725,865	3/31/2020
2019 Q4	2/6/2020	27,294	0.0%	5,346,426	12/31/2019
2014 Q1	5/15/2014	38,993	0.0%	2,611,643	3/31/2014
2013 Q4	2/6/2014	36,937	0.0%	2,517,764	12/31/2013